Key Points Building on a strong 2025, CVS Health's outlook for 2026 and beyond looks promising. Amgen is developing newer drug products that will address a recent patent cliff. Both stocks are strong options for dividend seekers to add to their portfolios. 10 stocks we like better than CVS Health › Last year was a rebound one for CVS Health (NYSE: CVS) and Amgen (NASDAQ: AMGN). After underperforming broader equities in 2024, both healthcare giants bounced back in 2025, outperforming the market ha ...